The mechanisms leading to clear cell renal cell carcinoma (ccRCC) metastases are still unclear. This study identified FOXO3a as a key factor in ccRCC metastasis using transcriptional profiling of ccRCC samples. FOXO3a was found to be attenuated in primary metastatic ccRCC samples. The loss of FOXO3a was an independent prognostic factor for ccRCC metastasis. Overexpression of FOXO3a inhibited renal cancer cell lines metastasis in vitro and in vivo. Moreover, FOXO3a downregulation was found to up-regulate SNAIL1, thereby promoting renal cancer cell metastasis.
Introduction
Renal cell carcinoma (RCC) represents approximately 2-3% of all human malignancies, and its most common histological subtype is the clear cell RCC (ccRCC), accounting for 80-90% of all RCCs (1) . Localised and metastatic ccRCC considerably differ in terms of prognosis and therapeutic approach. Indeed, the 5-year cancer-specific survival is less than 27.1% in metastatic ccRCC, but exceeds 70% in non-metastatic ccRCC (2). Currently, the only method for diagnosing metastatic ccRCC is based on imagery techniques, because of the lack of reliable molecular markers that could be used for the early detection of metastatic ccRCC.
Previous studies showed that ccRCC was associated with the loss of von Hippel-Lindau (VHL) gene, and the subsequent accumulation of hypoxia-inducible factors (HIFs) (3) (4) . Moreover, the target genes of HIFs were found to promote ccRCC metastasis (5) (6) . However, a clinical study by Young et al. (7) showed that the VHL status was not correlated with poor disease outcomes. Therefore, other mechanisms beyond the VHL-HIFs signal might promote ccRCC metastasis and could be used as a metastases marker.
Therefore, the aim of the present study was to explore the underlying mechanisms of ccRCC metastasis using primary metastatic (PM) and primary non-metastatic (PN) patients. Patients in the PN cohort were followed up for 29-mer scrambled shRNA (TR30013) were purchased from OriGene (Rockville, MD, USA).
The shRNA sequences inserted into pGFP-V-RS are shown in Supplementary   Table S3 . Transfections were conducted using the jetPRIME reagent as described above. At 24 hours after transfection, cells were subcultured in selective medium (2 ȝg/ml Puromycin for PEGF-V-RS or 800 ȝg/ml G418 for pIRES2-EGFP) for two weeks to select stable cell lines. All plasmids used were analyzed by direct sequence analysis to confirm the identities of the inserted sequences. The efficiency of transfection was evaluated by Western-blot assay and real-time RT-PCR. 
Migration and invasion assays
Cellular migration and invasion assays were performed using a Boyden
Chamber containing 24-well transwell plates (Corning Inc., Corning, NY, USA) with 8-ȝm pores on the membrane. All experiments were performed in duplicate and repeated three times.
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Author Manuscript Published OnlineFirst on January 31, 2014; DOI: 10.1158/1078-0432.CCR- For the migration assays, approximately 5×10 4 cells in 200 ȝl culture medium supplemented with 5% FBS were seeded into the upper chamber. The lower chamber was filled with the complete medium (with 10% FBS) as a chemoattractant. After 12 h of incubation at 37 °C in a 5% CO 2 atmosphere, the membranes containing the cells were fixed and stained with crystal violet. The lower surfaces of the membranes were photographed at 100× magnification. Five random fields were photographed for each chamber to determine the migration.
For the invasion assays, the membrane was coated with 50 ȝl 1:3 diluted matrigel (BD Biosciences). After the matrigel had solidified at 37 °C, approximately 1×10 5 cells in 200 ȝl culture medium supplemented with 1% FBS was seeded into the upper chamber, whereas the lower chamber was filled with the complete medium.
Subsequently, the Boyden chamber was incubated at 37 °C with a 5% CO 2 atmosphere for 24 h. The subsequent staining and observation procedures were identical to those of the migration assays.
In vivo orthotopic xenograft tumor model
Four-to six-week old male BALB/c nude mice (Charles River Laboratories, Wilmington, MA, USA) with a mean body weight of 20 g were used to establish orthotopic xenograft tumor models. The mice were housed and fed under specific pathogen-free conditions. The animal models in this study were approved by the were injected into the right kidney of the nude mouse. All mice were sacrificed at 7
weeks after the injection, and the kidneys and lungs were harvested. Immediately after the harvest of the xenografts and lung tissues, the GFP fluorescence of the samples was detected and analyzed in vitro using a molecular imaging system (NightOWL II LB 983, Berthold, Germany). The signal intensity of the GFP fluorescence from the lung tissues represented the amount of lung metastatic lesions. Subsequently, the xenografts and lung tissues were fixed in 10% neutral formalin and embedded in paraffin. Hematoxylin-eosin (HE) staining was performed on 4 ȝm sections by routine procedures to identify the tumor lesions.
Statistical analysis
Statistical analysis was performed using SPSS 12.0 (SPSS Inc., Chicago, IL, USA). Normally distributed data are expressed as mean ± standard deviation (SD) and comparisons were performed using Student's t-tests. Abnormally distributed data are expressed as median with interquartile range and comparisons were performed using 
Results

Bioinformatics analysis of the DEGs between PM and PN ccRCC tissues
To explore the biological mechanism promoting ccRCC metastasis, we Table S4 ). We further analyzed the pathways that were significantly enriched with DEGs, based on the KEGG database.
These pathways and their interaction net are shown in Supplementary Figure S1 .
Similar to the GO analysis results, identified pathways included those related to cell adhesion, cell cycle, cytoskeleton regulation and apoptosis.
To obtain specific genes promoting ccRCC metastasis, we performed a Decreased FOXO3a levels were an independent prognosis factor for ccRCC metastasis.
To study the association between clinicopathological variables and the prognosis of PN ccRCC, we followed up 114 PN ccRCC patients for 14.1-41.5 months (median of 28.2 months). We first analyzed the relationship between FOXO3a levels and prognosis in PN ccRCC patients through univariate Cox regression analysis. Since an arbitrary threshold of low or high FOXO3a level may strongly influence the statistical outcomes, we ranked the entire PN ccRCC dataset based on the FOXO3a expression levels and subsequently selected nine thresholds from the 10th percentile to the 90th percentile. Univariate Cox regression analysis based on these thresholds was performed. The corresponding P-values of these thresholds are shown in Figure 1E .
Except for the extremely high threshold level (P80 and P90 in this dataset), the low-FOXO3a groups (P10 to P70) always had a poor prognosis (P<0.05). Therefore, we selected the median of the dataset as the threshold in subsequent studies.
Furthermore, the effect of FOXO3a expression on prognosis was still significant in Table 1 ). The Kaplan-Meier analysis demonstrated that the patients with low FOXO3a levels (below the median) had a poorer metastasis-free survival than those belonging to the high FOXO3a levels (log-rank test, P=0.003; Figure 1F ).
FOXO3a inhibited the migration and invasion of RCC cell lines
The above mentioned data prompted further study of FOXO3a biological functions. We speculated that repression of FOXO3a was an underlying mechanism that promoted ccRCC metastasis. Based on the observed FOXO3a protein levels in were implanted into the right kidney of the respective nude mice. As shown in Figure   4D , FOXO3a expression in the kidney tissue of the FOXO3a+ group was higher than in the empty vector control group. Metastatic lesions were found in the peripheral lung field ( Figure 3A f ) and in the lung hilum ( Figure 3A g ) 7 weeks after implantation. As shown in Table 2 , 100% (17/17) of the xenografts formed primary tumors. Tumor weight was similar between groups (P=0.49). In the empty vector control group, metastasis occurred in the lungs of 100% (8/8) of the mice. In the FOXO3a+ group, lung metastasis rate was only 55.6% (5/9), which was lower than that in the empty vector group. However, this difference was not significant (P = 0.082).
Lowly-aggressive xenografts developed less metastatic lesions at the same period.
Therefore, the inhibitory effect of FOXO3a on metastasis could be assessed based on the metastasis rate and the amount of the metastatic lesions. The SN12-PM6 FOXO3a+ and empty vector control cell lines expressed GFP, which could be detected and quantified by a molecular imaging system. Thus, we measured all lung metastatic lesions using this system. As shown in Figures 3B, 3C and 3D, the mean GFP fluorescence intensity in the lung in the FOXO3a+ group was significantly decreased, compared with that in the empty vector group (P=0.026). Therefore, the amount of metastatic lesions was decreased in the FOXO3a+ group. Based on the above mentioned results, we concluded that FOXO3a could suppress tumor metastasis 
Attenuation of FOXO3a activated EMT through the upregulation of SNAIL1 expression in vitro and in vivo
Given that FOXO3a suppresses tumor cell metastasis in vitro and in vivo, we further explored the mechanism by which FOXO3a suppressed metastasis in ccRCC cell lines. GO enrichment and pathway analysis of the microarray data revealed a probable EMT in the metastatic ccRCC group. In Figure 2A 
Discussion
The aim of the present study was to explore the underlying mechanisms of ccRCC metastasis. Bioinformatics analysis, including GO enrichment and pathway analysis, indicated that EMT probably occurred in the PM ccRCC groups. EMT has been defined as a possible mechanism of metastasis (24). EMT could transform the epithelial tumor cells and confer the mesenchymal characteristics that would facilitate the dissemination of tumor cells, leading to metastases (25). Moreover, some studies reported that EMT influences ccRCC progression (26). Therefore, we assumed that ccRCC metastasis might be promoted by EMT in tumor cells.
GO enrichment and pathway analysis could only describe systematic information of biological processes, and the identification of specific genes with crucial functions from the list of redundant DEGs was a major challenge. Jia et al (27) successfully identified the crucial genes by combining the results of signal-net analysis with PubMed data. In our study, 6 DEGs were initially selected by the signal-net analysis. Of these 6 DEGs, LAMA4 is involved in blood vessel development and is a marker of vascularity in certain types of cancers (28). ATR has a role in p53 activation and renal cell apoptosis (29). JUN and ETS1 are reported oncogenes promoting tumor cell metastasis (30). However, according to microarray results, both DEGs were downregulated in PM ccRCC. SORBS2 acts as an adapter protein to assemble signaling complexes for regulating actin-dependent processes, such as cell adhesion and migration (31). FOXO3a is a transcriptional factor belonging to the forkhead family. Among these DEGs, FOXO3a was considered the most attractive for further study.
In the immunohistochemistry assays, we found that the intracellular location of FOXO3a in the ccRCC tissues was different from that in the adjacent normal kidney tissues. In the adjacent normal tissues, FOXO3a was found strongly positive in the nucleus and slightly positive in the cytoplasm, whereas in the ccRCC tissues, FOXO3a was found mainly localized in the nucleus and was attenuated significantly. Author Manuscript Published OnlineFirst on January 31, 2014; DOI: 10.1158/1078-0432.CCR- cytoplasm in the adjacent normal tissues, whereas it was found mainly localized in the nucleus in the ccRCC tissues. Previous studies showed that the intracellular localization of FOXO3a is closely related to its activity (34) . Phosphorylation of FOXO3a by AKT, IKK, or ERK results in FOXO3a translocation from the nucleus to the cytoplasm, and subsequent degradation, whereas phosphorylation by c-jun-NH2-kinase results in retaining FOXO3a in the nucleus and thereby increasing FOXO3a activity (35) . We believe that the detailed regulation mechanism of FOXO3a expression were complex and attractive, and further studies are required to shed light on this point.
The FOXO3a protein is significantly downregulated in renal cancer, compared with adjacent normal kidney tissues. Activation of FOXO3a could function as a tumor suppressor promoting cell cycle arrest and apoptosis in RCC cell lines (36) . In the present study, we found that FOXO3a mRNA levels were dramatically suppressed in PM ccRCC compared with PN ccRCC. Immunohistochemistry confirmed that FOXO3a protein levels were decreased in PM ccRCC tissues, which correlated with the observed mRNA levels. Therefore, we present the first report suggesting that low FOXO3a mRNA levels are an independent prognostic factor for ccRCC metastasis, based on multivariate Cox regression analysis. This phenomenon implies that FOXO3a expression could serve as a possible marker for distinguishing ccRCC patients with a high risk of metastasis. However, more studies with larger sample sizes are required to draw robust conclusions about this point.
To date, reports on the role of FOXO3a in metastasis development are 
controversial. Some studies reported that FOXO3a activation could reverse the invasive phenotype of breast cancer cells (37) 
P=0.003).
* P < 0.05; ** P < 0.01; *** P<0.001. 
